NCT03863132View on ClinicalTrials.gov

accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

September 1, 2027

Study Completion Date

March 1, 2028

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

TAVR

Repair of defective aortic valve by microsurgical Intervention.

Trial Locations (1)

81377

Klinikum der Universität München-Großhadern, München

Sponsors

Collaborators (1)

Boston Scientific Group
All Listed Sponsors
collaborator

Boston Scientific Group

UNKNOWN

collaborator

Yale University

OTHER

lead

IHF GmbH - Institut für Herzinfarktforschung

OTHER

NCT03863132 - accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis | Biotech Hunter | Biotech Hunter